Skip to content

Meet the Committee Members

The Women’s Venture Competition review committees are comprised of a combination of world-class life sciences industry professionals, investors and entrepreneurs from within the extensive network of the National Foundation for Cancer Research, the non-profit affiliate of the AIM-HI Accelerator Fund.

This competition is designed to provide women scientist-entrepreneurs with advising, coaching and continuous access to our valuable global network to advance their innovative oncology technologies that can save patients’ lives. Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!

Judging Committee:

Raju Kucherlapati (1)

Raju Kucherlapati, Ph.D. | Co-Chair

Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School

Beverly Lu, Ph.D. | Co-Chair

Investment Manager, Health, Emerson Collective

Anna D. Barker, Ph.D.

Chief Strategy Officer, Lawrence J. Ellison Institute for Transformative Medicine

Webster Cavenee

Webster Cavenee, Ph.D.

Director of Strategic Alliances, Ludwig Institute for Cancer Research

Aleksandra Filipovic, M.D., Ph.D.

Head of Oncology, PureTech Health

Pamela Garzone

Pamela Garzone, Ph.D.

Chief Development Officer, Anixa Biosciences

Scott Lippman, M.D.

Distinguished Professor of Medicine & Associate Vice Chancellor for Cancer Research

Eva Martin, M.D.

Senior Director, Alliance and Asset Management, Roche Pharma Partnering

Tom-Miller

Tom Miller

Founder & Managing Partner, GreyBird Ventures

Kornelia Polyak, M.D., Ph.D.

Professor of Medicine, Dana-Farber Cancer Institute

Suzanne Topalian, M.D.

Associate Director, Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University

Michael Salgaller, Ph.D.

Supervisory Invention Development & Marketing Specialist, National Institutes of Health/National Cancer Institute

Selection Committee:

Pamela Garzone

Pamela Garzone, Ph.D. | Co-Chair

Chief Development Officer, Anixa Biosciences

Raju Kucherlapati (1)

Raju Kucherlapati, Ph.D. | Co-Chair

Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School

Webster Cavenee

Webster Cavenee, Ph.D.

Director of Strategic Alliances, Ludwig Institute for Cancer Research

Dimitra Georganopoulou, Ph.D.

Innovation – Investment | General Partner, Qral Ventures

Brian Leyland-Jones, MBBS, Ph.D.

Chief Medical Officer, AIM-HI Accelerator Fund

Scott Lippman, M.D.

Distinguished Professor of Medicine & Associate Vice Chancellor for Cancer Research

Beverly Lu, Ph.D.

Investment Manager, Health, Emerson Collective

Eva Martin, M.D.

Senior Director, Alliance and Asset Management, Roche Pharma Partnering

Tom-Miller

Tom Miller

Founder & Managing Partner, GreyBird Ventures

Fei Shen, Ph.D.

Managing Director, Boehringer Ingelheim Venture Fund USA

Investment Committee:

Jimmy Lu, J.D., MBA | Chair

Co-Founder, R3 Bio

Patty Obermaier

Vice President, US Health and Life Sciences, Microsoft

Chih-Kao Hu, Ph.D., MBA

Management Consultant, Qral Group

Kim Kamdar, Ph.D.

Managing Partner, Medical Excellence Capital

Monica Bertagnolli, M.D. | Co-Chair

Richard E. Wilson Professor of Surgery in the Field of Surgical Oncology, Harvard Medical School

Robbert Tepper

Robert Tepper, M.D.

Partner, Third Rock Ventures

Yajun Xu, Ph.D.

Managing Partner, Hongsen Capital

Michael Wang, M.D., Ph.D., MBA

Chief Science Officer, AIM-HI Accelerator Fund

Thea Tlsty, Ph.D.

Professor of Pathology, University of California San Francisco

Matt Tremblay, Ph.D.

Chief Operating Officer, Scripps Research

Huijun (HJ) Yang, Ph.D.

President, Yang Management, Inc.

Back To Top